Bellon Steven F. 4
4 · Foghorn Therapeutics Inc. · Filed Aug 15, 2022
Insider Transaction Report
Form 4
Bellon Steven F.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-08-11$3.72/sh+1,858$6,912→ 121,957 total - Exercise/Conversion
Stock Options (Right to buy)
2022-08-11−1,858→ 3,716 totalExercise: $3.72Exp: 2029-02-12→ Common Stock (1,858 underlying)
Holdings
- 50,000(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Shares held by the Steven F. Bellon 2021 Irrevocable Trust dated December 3, 2021, of which the Reporting Person's children are the trustees.
- [F2]The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.